Capan‐1 cells showed significantly higher sensitivity to chlorambucil, as well as to cisplatin and olaparib, when compared to MIA PaCa‐2 pancreatic cancer cells with normal BRCA2 expression (Fig 3A). Here, BRCA2 is linked to familial pancreatic carcinoma.